Shota Fukuoka, MD, physician, National Cancer Center in Japan, discusses finding the recommended dosage of regorafenib plus nivolumab in patients with advanced gastric cancer or colorectal cancer.
Shota Fukuoka, MD
Advertisement
Articles by Shota Fukuoka, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Data Refine the Role of Immunotherapy Across Early-Stage NSCLC Settings
2
Dr Tarantino on the Evolution of TROP2-Directed ADCs in First-Line TNBC
3
Dr Hurvitz on Updated PFS Data From the SERENA-6 Trial in Breast Cancer
4
Ris-Rez Meets Phase 3 Efficacy End Point for R/R Osteosarcoma
5